Your browser doesn't support javascript.
loading
PPARγ agonists promote the resolution of myelofibrosis in preclinical models.
Lambert, Juliette; Saliba, Joseph; Calderon, Carolina; Sii-Felice, Karine; Salma, Mohammad; Edmond, Valérie; Alvarez, Jean-Claude; Delord, Marc; Marty, Caroline; Plo, Isabelle; Kiladjian, Jean-Jacques; Soler, Eric; Vainchenker, William; Villeval, Jean-Luc; Rousselot, Philippe; Prost, Stéphane.
Afiliação
  • Lambert J; Division of Innovative Therapies, CEA/DRF/François Jacob Biology Institute, UMR1184 IMVA-HB/IDMIT, Université Paris-Saclay, Fontenay-aux-Roses, France.
  • Saliba J; Department of Hematology and Oncology, Centre Hospitalier de Versailles, Le Chesnay, France.
  • Calderon C; Opale Carnot Institute, Paris, France.
  • Sii-Felice K; Division of Innovative Therapies, CEA/DRF/François Jacob Biology Institute, UMR1184 IMVA-HB/IDMIT, Université Paris-Saclay, Fontenay-aux-Roses, France.
  • Salma M; Division of Innovative Therapies, CEA/DRF/François Jacob Biology Institute, UMR1184 IMVA-HB/IDMIT, Université Paris-Saclay, Fontenay-aux-Roses, France.
  • Edmond V; Opale Carnot Institute, Paris, France.
  • Alvarez JC; Division of Innovative Therapies, CEA/DRF/François Jacob Biology Institute, UMR1184 IMVA-HB/IDMIT, Université Paris-Saclay, Fontenay-aux-Roses, France.
  • Delord M; Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
  • Marty C; Université de Paris, Laboratory of Excellence GR-Ex, Paris, France.
  • Plo I; INSERM, UMR1287, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
  • Kiladjian JJ; Département de Pharmacologie-Toxicologie, Hôpitaux Universitaires Paris Ile-de-France Ouest, AP-HP, Hôpital Raymond-Poincaré, FHU Sepsis, Garches, France.
  • Soler E; MasSpecLab, Plateforme de spectrométrie de masse, INSERM U-1173, Université Paris-Saclay (Versailles Saint-Quentin-en-Yvelines), UFR des sciences de la santé, Montigny-le-Bretonneux, France.
  • Vainchenker W; Recherche Clinique, Centre Hospitalier de Versailles, Le Chesnay, France.
  • Villeval JL; INSERM, UMR1287, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
  • Rousselot P; INSERM, UMR1287, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
  • Prost S; Opale Carnot Institute, Paris, France.
J Clin Invest ; 131(11)2021 06 01.
Article em En | MEDLINE | ID: mdl-33914703
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / PPAR gama / Mielofibrose Primária / Proteínas de Neoplasias / Neoplasias Experimentais / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / PPAR gama / Mielofibrose Primária / Proteínas de Neoplasias / Neoplasias Experimentais / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França